These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 7488736

  • 21. The role of delta-opioid receptor subtypes in cocaine- and methamphetamine-induced place preferences.
    Suzuki T, Mori T, Tsuji M, Misawa M, Nagase H.
    Life Sci; 1994; 55(17):PL339-44. PubMed ID: 7934637
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Attenuation of morphine tolerance and dependence with the highly selective delta-opioid receptor antagonist TIPP[psi].
    Fundytus ME, Schiller PW, Shapiro M, Weltrowska G, Coderre TJ.
    Eur J Pharmacol; 1995 Nov 03; 286(1):105-8. PubMed ID: 8566146
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Morphine discriminative control is mediated by the mu opioid receptor: assessment of delta opioid substitution and antagonism.
    Stevenson GW, Cañadas F, Zhang X, Rice KC, Riley AL.
    Pharmacol Biochem Behav; 2000 Aug 03; 66(4):851-6. PubMed ID: 10973525
    [Abstract] [Full Text] [Related]

  • 31. Antagonism of heroin and morphine self-administration in rats by the morphine-6beta-glucuronide antagonist 3-O-methylnaltrexone.
    Walker JR, King M, Izzo E, Koob GF, Pasternak GW.
    Eur J Pharmacol; 1999 Oct 27; 383(2):115-9. PubMed ID: 10585524
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
    Randich A, Robertson JD, Willingham T.
    Brain Res; 1993 Feb 19; 603(2):186-200. PubMed ID: 8096421
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Blockade of delta-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release.
    Acquas E, Meloni M, Di Chiara G.
    Eur J Pharmacol; 1993 Jan 12; 230(2):239-41. PubMed ID: 8380771
    [Abstract] [Full Text] [Related]

  • 40. Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation.
    Reid LD, Hubbell CL, Tsai J, Fishkin MD, Amendola CA.
    Pharmacol Biochem Behav; 1996 Feb 12; 53(2):477-80. PubMed ID: 8808161
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.